Dr. Farhad Ravandi-Kashani
Claim this profileM D Anderson Cancer Center
Area of expertise
Acute Myeloid Leukemia
Farhad Ravandi-Kashani has run 6 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Acute Myelogenous Leukemia
Farhad Ravandi-Kashani has run 5 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
M D Anderson Cancer Center
The University Of Texas M.D. Anderson Cancer Center
Clinical Trials Farhad Ravandi-Kashani is currently running
Combination Chemotherapy + Nelarabine
for Leukemia and Lymphoma
This phase II trial studies the side effects and how well combination chemotherapy and nelarabine work in treating patients with T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma. Drugs used in chemotherapy, such as cyclophosphamide, vincristine, doxorubicin, dexamethasone, methotrexate, cytarabine, mercaptopurine, prednisone, pegaspargase, nelarabine, and venetoclax work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting
1 award
Phase 2
Cladribine + Rituximab
for Hairy Cell Leukemia
This trial studies how well two drugs, cladribine and rituximab, work together in treating patients with hairy cell leukemia. Cladribine helps stop cancer cells from growing, while rituximab helps the immune system attack cancer cells. The combination aims to be more effective in treating this type of leukemia.
Recruiting
3 awards
Phase 2
More about Farhad Ravandi-Kashani
Clinical Trial Related
4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Farhad Ravandi-Kashani has experience with
- Venetoclax
- Cladribine
- Dexamethasone
- Arsenic Trioxide
- Gemtuzumab Ozogamicin
- Tretinoin
Breakdown of trials Farhad Ravandi-Kashani has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Farhad Ravandi-Kashani specialize in?
Farhad Ravandi-Kashani focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved FLT3 positive patients, or patients who are undergoing treatment.
Is Farhad Ravandi-Kashani currently recruiting for clinical trials?
Yes, Farhad Ravandi-Kashani is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Farhad Ravandi-Kashani has studied deeply?
Yes, Farhad Ravandi-Kashani has studied treatments such as Venetoclax, Cladribine, Dexamethasone.
What is the best way to schedule an appointment with Farhad Ravandi-Kashani?
Apply for one of the trials that Farhad Ravandi-Kashani is conducting.
What is the office address of Farhad Ravandi-Kashani?
The office of Farhad Ravandi-Kashani is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.